1
Total investments
0
Early stage
0
Mid stage
0
Late stage
1y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Advisor
Aug 2025
We are helping families gain access to type 1 diabetes screening through our at-home DNA saliva test kit and at-home autoantibody kit. This no-nonsense programs means adults and children can screen to spot T1D in the earlier stages — before you need daily insulin therapy. An early diagnosis means preventing diabetic ketoacidosis (DKA) and taking advantage of FDA-approved therapies and clinical trials striving to delay the full onset of T1D.
Experience · 3 entries
All (3)
Investments (1)
Founder (1)
2025
Investor and Advisor
Aug 2025
We are helping families gain access to type 1 diabetes screening through our at-home DNA saliva test kit and at-home autoantibody kit. This no-nonsense programs means adults and children can screen to spot T1D in the earlier stages — before you need daily insulin therapy. An early diagnosis means preventing diabetic ketoacidosis (DKA) and taking advantage of FDA-approved therapies and clinical trials striving to delay the full onset of T1D.
Founder
Jul 2025
Modai is a boutique biopharma consultancy that partners with investors, founders, and technical teams to accelerate regulatory readiness, facility deployment, and market entry.
We provide fractional executive leadership and specialized guidance in CMC strategy, cleanroom integration, and commercialization across therapeutics, diagnostics, and enabling infrastructure.
Our clients include life science ventures, modular cleanroom manufacturers, and compliance services firms navigating scale, complexity, or regulatory inflection points.
2023
M&A Advisor
Feb 2023
Verista is a leading business and technology consultancy firm that provides systems, compliance, validation and quality solutions to life science companies - enabling them to improve health and improve lives. We help clients solve their most critical and complex challenges across the GxP lifecycle, from preclinical and clinical to commercialization, manufacturing and distribution – bringing together decades of knowledge, the most advanced engagement platforms and transformative technologies. This allows clients to benefit from the ease, efficiency and trust that results from working with one partner who excels across specialties. Verista’s clients trust the company’s 650+ experts to deliver consistent, safe, and high-quality results across the product development lifecycle. Verista is based in Fishers, Indiana, Wayne, Pennsylvania, Westford, Massachusetts, and San Mateo, California. For more information, visit www.verista.com
